PCDPrivate Comps Data

Company record · updated August 5, 2026

Metagenomi, Inc.: 7 valuation observations from SEC filings

Every row below names the filing it came from. Coverage for this company runs February 5, 2024 to February 5, 2024.

7observations
1source filings
7verified rows
2024-02-05most recent as-of date

Source rails for this company: S-1 charter round (7).

As ofMeasureValueReported byTier What the filing saysAccession
2024-02-05 Series B-1 price per share 14.0677 USD VERIFIED "Original Issue Price" defined for Series B-1 000119312524023377
2024-02-05 Series B price per share 11.6495 USD VERIFIED "Original Issue Price" defined for Series B 000119312524023377
2024-02-05 Series A-5 price per share 6.3254 USD VERIFIED "Original Issue Price" defined for Series A-5 000119312524023377
2024-02-05 Series A-4 price per share 4.8487 USD VERIFIED "Original Issue Price" defined for Series A-4 000119312524023377
2024-02-05 Series A-3 price per share 1.1713 USD VERIFIED "Original Issue Price" defined for Series A-3 000119312524023377
2024-02-05 Series A-2 price per share 0.6456 USD VERIFIED "Original Issue Price" defined for Series A-2 000119312524023377
2024-02-05 Series A-1 price per share 3.2325 USD VERIFIED "Original Issue Price" defined for Series A-1 000119312524023377

Reading these figures

A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.